Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 3
1994 3
1995 4
1996 2
1997 1
1998 2
1999 1
2000 3
2002 2
2003 3
2004 3
2005 4
2006 4
2007 1
2008 5
2009 12
2010 7
2011 7
2012 7
2013 4
2014 3
2015 5
2016 6
2017 7
2018 3
2019 2
2020 3
2021 4
2022 9
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy.
Oldroyd AGS, Lilleker JB, Amin T, Aragon O, Bechman K, Cuthbert V, Galloway J, Gordon P, Gregory WJ, Gunawardena H, Hanna MG, Isenberg D, Jackman J, Kiely PDW, Livermore P, Machado PM, Maillard S, McHugh N, Murphy R, Pilkington C, Prabu A, Rushe P, Spinty S, Swan J, Tahir H, Tansley SL, Truepenny P, Truepenny Y, Warrier K, Yates M, Papadopoulou C, Martin N, McCann L, Chinoy H; British Society for Rheumatology Standards, Audit and Guidelines Working Group. Oldroyd AGS, et al. Among authors: kiely pdw. Rheumatology (Oxford). 2022 May 5;61(5):1760-1768. doi: 10.1093/rheumatology/keac115. Rheumatology (Oxford). 2022. PMID: 35355064 Free PMC article. No abstract available.
EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases.
Krieckaert CL, van Tubergen A, Gehin JE, Hernández-Breijo B, Le Mélédo G, Balsa A, Böhm P, Cucnik S, Elkayam O, Goll GL, Hooijberg F, Jani M, Kiely PD, McCarthy N, Mulleman D, Navarro-Compán V, Payne K, Perry ME, Plasencia-Rodriguez C, Stones SR, Syversen SW, de Vries A, Ward KM, Wolbink G, Isaacs JD. Krieckaert CL, et al. Among authors: kiely pd. Ann Rheum Dis. 2023 Jan;82(1):65-73. doi: 10.1136/annrheumdis-2022-222155. Epub 2022 May 12. Ann Rheum Dis. 2023. PMID: 35551063
Fluorosis and osteomalacia.
Kiely PD, Chow J, Eastwood JB, Bourke BE. Kiely PD, et al. Arthritis Rheum. 1999 Sep;42(9):2012-3. doi: 10.1002/1529-0131(199909)42:9<2012::AID-ANR31>3.0.CO;2-W. Arthritis Rheum. 1999. PMID: 10513821 Free article. No abstract available.
Biologic agents for rheumatoid arthritis--negotiating the NICE technology appraisals.
Kiely PD, Deighton C, Dixey J, Ostör AJ; British Society for Rheumatology Standards, Guidelines and Audit Working Group. Kiely PD, et al. Rheumatology (Oxford). 2012 Jan;51(1):24-31. doi: 10.1093/rheumatology/ker321. Epub 2011 Oct 27. Rheumatology (Oxford). 2012. PMID: 22039226 Free PMC article. Review.
106 results